VERIGENE GRAM POSITIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GP)— 510(k) DEN120014

Unknown

Nanosphere, Inc.

FDA 510(k) clearance DEN120014 for VERIGENE GRAM POSITIVE BLOOD CULTURE NUCLEIC ACID TEST (BC-GP), Unknown on 2012-06-26. Applicant: Nanosphere, Inc..

Clearance details

Applicant: Nanosphere, Inc.
Product code: Code PAM
Advisory panel: Microbiology
Date received: 2012-06-15
Decision date: 2012-06-26
Decision: Unknown
Clearance type: Post-NSE
Location: Northbrook, IL, US

View on FDA.gov ↗

Adverse events under product code PAM

product code PAM

Death: 6
Malfunction: 598
Total: 604

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.